Opportunities and Challenges for Molded and Extruded Long-Acting Dosage Forms
Tuesday, July 27th - 12pm (Noon) EDT
|
Sponsored By:
|
|
Site-specific, controlled release of therapeutic agents represents an attractive option for companies looking to improve patient compliance, enhance the efficacy or usability of an existing drug product, or provide additional benefit in conjunction with an implantable device. This Tech Forum will review some
of the most common durable and biodegradable polymeric materials for delivery of potent compounds such as hormones, opioids, antibiotics, and oncology drugs. Product design considerations related to the use of injection molding and hot melt extrusion processes for drug-eluting implants and related dosage forms will be described from early-stage feasibility to pilot and commercial scale. Applications and examples from diverse therapeutic areas such as ophthalmology and women’s health will be presented with an eye toward next-generation opportunities.
of the most common durable and biodegradable polymeric materials for delivery of potent compounds such as hormones, opioids, antibiotics, and oncology drugs. Product design considerations related to the use of injection molding and hot melt extrusion processes for drug-eluting implants and related dosage forms will be described from early-stage feasibility to pilot and commercial scale. Applications and examples from diverse therapeutic areas such as ophthalmology and women’s health will be presented with an eye toward next-generation opportunities.
